Inhibition of epidermal growth factor binding to HeLa cells by auranofin
- 1 March 1987
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 36 (5), 769-772
- https://doi.org/10.1016/0006-2952(87)90733-7
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Cellular and molecular pharmacology of auranofin and related gold complexesBiochemical Pharmacology, 1986
- EGF receptor affinity is regulated by intracellular calcium and protein kinase CCell, 1985
- Diacylglycerol inhibits gap junctional communication in cultured epidermal cells: Evidence for a role of protein kinase CBiochemical and Biophysical Research Communications, 1985
- Modulation of Ca2+-activated, phospholipid-dependent protein kinase in platelets treated with a tumor-promoting phorbol esterBiochemical and Biophysical Research Communications, 1984
- Calcium messenger system: an integrated view.Physiological Reviews, 1984
- Disappearance of Ca2+-sensitive, phospholipid-dependent protein kinase activity in phorbol ester-treated 3T3 cellsBiochemical and Biophysical Research Communications, 1984
- Platelet Ca2+-activated, phospholipid-dependent protein kinase: Evidence for proteolytic activation of the enzyme in cells treated with phospholipase CBiochemical and Biophysical Research Communications, 1984
- Phorbol esters increase the amount of Ca2+, phospholipid-dependent protein kinase associated with plasma membraneNature, 1983
- Inhibition of epidermal growth factor binding to cultured mouse epidermal cells by tumor promotersCarcinogenesis: Integrative Cancer Research, 1980
- Biologically active phorbol esters specifically alter affinity of epidermal growth factor membrane receptorsNature, 1979